Julien Blouin

Stock Analyst at Goldman Sachs

(1.88)
# 3,159
Out of 5,173 analysts
28
Total ratings
52.38%
Success rate
-1.08%
Average return

Stocks Rated by Julien Blouin

UDR, Inc.
Jan 20, 2026
Maintains: Sell
Price Target: $33$38
Current: $34.26
Upside: +9.46%
Healthpeak Properties
Jan 9, 2026
Initiates: Neutral
Price Target: $17
Current: $17.17
Upside: -0.99%
Jones Lang LaSalle
Nov 26, 2025
Maintains: Buy
Price Target: $361$407
Current: $299.60
Upside: +35.85%
Camden Property Trust
Sep 17, 2025
Downgrades: Sell
Price Target: $118$106
Current: $98.15
Upside: +8.00%
American Homes 4 Rent
Sep 17, 2025
Downgrades: Neutral
Price Target: $43$37
Current: $27.54
Upside: +34.35%
Cushman & Wakefield
Aug 13, 2025
Maintains: Buy
Price Target: $18$20
Current: $12.27
Upside: +63.00%
Millrose Properties
May 15, 2025
Maintains: Buy
Price Target: $28$32
Current: $28.63
Upside: +10.02%
Invitation Homes
May 6, 2025
Maintains: Buy
Price Target: $39$43
Current: $24.76
Upside: +73.67%
Newmark Group
Mar 19, 2025
Maintains: Buy
Price Target: $20$17
Current: $14.55
Upside: +16.84%
Colliers International Group
Mar 19, 2025
Maintains: Neutral
Price Target: $165$145
Current: $102.00
Upside: +42.16%
Initiates: Buy
Price Target: $176
Current: $135.75
Upside: +29.65%
Initiates: Neutral
Price Target: $318
Current: $242.58
Upside: +31.09%
Initiates: Neutral
Price Target: $81
Current: $58.41
Upside: +38.67%
Initiates: Buy
Price Target: $187
Current: $122.39
Upside: +52.79%